Treatment of core-binding-factor in acute myelogenous leukemia with fludarabine, cytarabine, and granulocyte colony-stimulating factor results in improved event-free survival-Reference-Cited by-同舟云学术

Treatment of core-binding-factor in acute myelogenous leukemia with fludarabine, cytarabine, and granulocyte colony-stimulating factor results in improved event-free survival

Published:2008-12-01 Issue:11 Volume:113 Page:3181-3185
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Borthakur Gautam,Kantarjian Hagop,Wang Xuemei,Plunkett William K.,Gandhi Varsha V.,Faderl Stefan,Garcia-Manero Guillermo,Ravandi Farhad,Pierce Sherry,Estey Elihu H.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference23 articles.

1. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt;Erickson;Blood,1992

2. Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia;Liu;Science,1993

3. Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(p13q22) or t(16;16)(p13;q22): results from CALGB 8461;Byrd;J Clin Oncol,2004

4. The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations;Appelbaum;Br J Haematol,2006

5. Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay;Marcucci;Leukemia,1998

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety of granulocyte colony-stimulating factor priming regimen for acute myeloid leukemia: A systematic review and meta-analysis of the Clinical Practice Guideline for the use of G-CSF 2022 from the Japan Society of Clinical Oncology;International Journal of Clinical Oncology;2024-05-17

2. Addition of single dose gemtuzumab ozogamicin to intensive induction chemotherapy in core-binding factor acute myeloid leukemia;Leukemia Research;2024-04

3. Clinical implications of additional chromosomal abnormalities in adult acute myeloid leukemia with inv (16)/t(16;16)/CBFB::MYH11;European Journal of Haematology;2024-02-22

4. The core concepts of core binding factor acute myeloid leukemia: Current considerations for prognosis and treatment;Blood Reviews;2023-11

5. Moving toward individualized target-based therapies in acute myeloid leukemia;Annals of Oncology;2023-02